Novo Nordisk (NVO) Earnings
|
Expand Research on NVO
| Next EPS Date | 8/5/26 | EPS Growth Rate | -93.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -92.8% |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | DKK0.82 | N/A | N/A | DKK11.23B | N/A | N/A | N/A | ||
| 5/6/26 |
Q126 | DKK6.63 | DKK6.96 | -DKK0.33 | DKK96.82B | DKK11.17B | N/A |  | | Details | |
| 2/3/26 |
Q425 | $1.02 | $0.92 | +$0.10 | $12.53B | $11.99B | N/A | | | Details | |
| 11/5/25 |
Q325 | DKK4.50 | N/A | N/A | DKK74.98B | DKK12.01B | N/A | | | Details | |
| 8/6/25 |
Q225 | DKK12.49 | N/A | N/A | DKK154.94B | DKK11.95B | N/A | | | Details | |
| 5/7/25 |
Q125 | DKK6.53 | N/A | N/A | DKK78.09B | DKK11.38B | N/A | | | Details | |
| 2/5/25 |
Q424 | DKK6.34 | N/A | N/A | DKK85.68B | DKK11.38B | N/A | | | Details | |
| 11/6/24 |
Q324 | DKK6.12 | N/A | N/A | DKK71.31B | DKK10.6B | N/A | | | Details |
